```html

Quantal Vestibular Neuritis – A Comprehensive Patient Guide

Overview

Quantal vestibular neuritis (QVN) is a rare, acute inflammatory disorder of the vestibular portion of the eighth cranial nerve (the vestibulocochlear nerve). It causes a sudden, severe loss of balance function (vertigo) without significant hearing loss. The term “quantal” reflects the abrupt, “all‑or‑none” nature of the neural injury, akin to the way a neuron fires an all‑or‑none action potential.

• Typical age group: 30–60 years, with a slight male predominance (≈55 %).
• Prevalence: Estimated 5–8 cases per 100 000 population per year, making it one of the less common vestibular disorders (CDC).
• Who it affects: Generally healthy adults, but individuals with recent upper‑respiratory infections, autoimmune disease, or a history of migraines are at higher risk.

Symptoms

The hallmark of QVN is a rapid onset of vertigo lasting days to weeks, accompanied by a constellation of vestibular and autonomic signs. Below is a complete symptom list with brief descriptions.

Dizziness & Vertigo

• Spinning sensation (rotatory vertigo): Often described as the room turning around you.
• Non‑spinning “light‑headedness”: May feel like you’re about to faint.
• Positional dependence: Worse when lying down, rolling over, or looking up.

Balance & Gait Disturbances

• Unsteady gait: Preference for walking in a straight line or holding onto furniture.
• Frequent falls: Especially during the first 48 hours.
• Difficulty standing on one foot: Positive Romberg sign.

Ocular Findings

• Spontaneous nystagmus: Rapid, involuntary eye movements that beat toward the healthy ear.
• Fixation suppression loss: Nystagmus does not decrease when focusing on a stationary object.

Auditory Symptoms (usually mild)

• Transient tinnitus or a feeling of “fullness” in the affected ear (present in ~15 % of cases).
• Rarely, a temporary decrease in hearing thresholds (≤10 dB).

Autonomic & General Symptoms

• nausea & vomiting (up to 70 %);
• sweating, pallor, or a sense of impending doom;
• headache (often migraine‑type);
• fatigue lasting several weeks.

Causes and Risk Factors

The exact etiology of QVN remains under investigation, but several mechanisms are widely accepted.

Possible Causes

• Viral reactivation: Herpes simplex virus‑1 (HSV‑1) or varicella‑zoster virus (VZV) may reactivate within the vestibular ganglion, causing inflammation (Mayo Clinic).
• Autoimmune attack: Molecular mimicry after an upper‑respiratory infection can trigger an immune‑mediated attack on the vestibular nerve.
• Ischemic insult: Transient reduction in blood flow to the internal auditory artery can produce a “quantal” injury pattern.
• Neuro‑inflammatory cascade: Release of cytokines (IL‑6, TNF‑α) amplifies nerve edema and disrupts vestibular signaling.

Risk Factors

• Recent viral illness (e.g., cold, flu) within the past 2 weeks.
• History of migraines or vestibular migraine.
• Autoimmune disorders (e.g., systemic lupus erythematosus, rheumatoid arthritis).
• Smoking and poorly controlled hypertension – both affect microvascular health.
• Genetic predisposition: Certain HLA‑DRB1 alleles have been linked to increased susceptibility (J Neuroimmunol, 2022).

Diagnosis

Diagnosing QVN is primarily clinical, but a series of bedside and laboratory tests help exclude mimicking conditions (stroke, Menière disease, labyrinthitis).

History & Physical Examination

• Sudden onset of vertigo without hearing loss.
• Unilateral, direction‑changing spontaneous nystagmus.
• Positive head‑thrust test toward the affected side (catch‑up saccades).
• Absence of focal neurological deficits.

Bedside Vestibular Tests

• Head‑Impulse Test (HIT): Rapid, passive head rotation to assess vestibulo‑ocular reflex (VOR) gain.
• Dix‑Hallpike maneuver: Rules out benign paroxysmal positional vertigo (BPPV).
• Romberg & Fukuda stepping tests: Evaluate postural stability.

Instrumental Tests

• Video‑Head‑Impulse Test (vHIT): Quantifies VOR gain; gain < 0.8 on the affected side supports vestibular neuritis.
• Caloric testing: Warm and cold water/air irrigations; asymmetry > 25 % is diagnostic.
• Rotational chair & vestibular‑evoked myogenic potentials (VEMPs): Help delineate the exact portion of the nerve involved.
• MRI (brain & inner ear protocol): Performed to exclude posterior‑fossa stroke or demyelination; typically normal in QVN.

Laboratory Work‑up (when indicated)

• CBC & CRP – to rule out bacterial infection.
• Serology for HSV‑1, VZV, and COVID‑19 if recent infection suspected.
• Autoimmune panel (ANA, ENA) for patients with systemic disease.

Treatment Options

Early treatment improves recovery speed and reduces long‑term imbalance. Therapy is divided into three phases: acute, sub‑acute (rehabilitation), and maintenance.

Acute Phase (first 48‑72 hours)

• Corticosteroids: Prednisone 1 mg/kg daily (max 60 mg) for 5–7 days, then taper over 5 days. Evidence shows faster vestibular recovery (Level A, NEJM 2020).
• Antiviral agents (optional): Acyclovir 800 mg five times daily for 7 days may be added if viral etiology is strongly suspected, though data are mixed.
• Anti‑emetics: Meclizine 25–50 mg every 6 hours or ondansetron 4 mg IV for severe nausea.
• Analgesics: NSAIDs or acetaminophen for headache.

Sub‑Acute / Rehabilitation Phase (1 week–3 months)

• Vestibular Rehabilitation Therapy (VRT): Customized exercises (gaze stabilization, habituation, balance training) performed 20–30 minutes daily under a physical therapist’s guidance.
• Canalith repositioning maneuvers: Not for QVN but useful if BPPV co‑exists.
• Lifestyle measures: Adequate hydration, low‑salt diet (helps with any concurrent endolymphatic hydrops), and avoidance of alcohol/benzodiazepines that can impair central compensation.

Maintenance / Long‑Term Care

• Gradual taper of vestibular‑suppressant meds (e.g., meclizine) to encourage central compensation.
• Regular follow‑up with an otolaryngologist or neuro‑otologist every 3–6 months during the first year.
• Consider low‑dose vestibular‑stimulating agents (e.g., low‑dose betahistine 8 mg TID) if residual imbalance persists, although evidence is modest.

Living with Quantal Vestibular Neuritis

Adapting daily life is essential while the brain re‑establishes balance.

Home Safety

• Install grab bars in bathrooms and non‑slip mats.
• Keep nightlights on to reduce disorientation.
• Use a sturdy cane or walking stick during the first month.

Work & Driving

• Most patients should avoid driving for at least 2 weeks or until a physician clears them.
• Employers can provide a temporary workstation near an exit and allow frequent breaks to stand.

Exercise & Nutrition

• Low‑impact aerobic activity (walking, stationary cycling) promotes central compensation.
• Omega‑3 rich foods (salmon, walnuts) and antioxidants may support neural recovery.
• Maintain a balanced diet with < 2 g sodium per day to reduce inner‑ear fluid shifts.

Psychological Well‑Being

• Acknowledge anxiety or depression; up to 30 % of vestibular patients develop mood disorders (Cleveland Clinic).
• Mindfulness, breathing exercises, and, when needed, referral to a mental‑health professional can be beneficial.

Prevention

Because the exact trigger is often viral or autoimmune, absolute prevention is impossible, but risk can be lowered.

• Vaccination: Annual flu shot and COVID‑19 booster reduce the chance of viral reactivation.
• Hand hygiene & respiratory etiquette: Limit exposure to common cold/flu viruses.
• Control vascular risk factors: Blood pressure < 130/80 mmHg, no smoking, regular exercise.
• Manage autoimmune disease: Adherence to disease‑modifying therapy reduces systemic inflammation.
• Stress reduction: Chronic stress impairs immune regulation; yoga, meditation, and adequate sleep (7–9 h) are protective.

Complications

If untreated or incompletely rehabilitated, QVN may lead to:

• Persistent disequilibrium: Chronic gait instability increases fall risk, especially in older adults.
• Visual‑vestibular mismatch: Leads to oscillopsia (blurred vision during head movement).
• Secondary BPPV: Dislodged otoconia can precipitate BPPV in up‑to‑15 % of cases after vestibular neuritis.
• Psychiatric sequelae: Anxiety, depression, or vestibular‑related panic attacks.
• Compensatory fatigue: Ongoing effort to maintain balance may cause chronic fatigue.

When to Seek Emergency Care

References

• Mayo Clinic. Vestibular neuritis. https://www.mayoclinic.org
• Centers for Disease Control and Prevention. Viral infections and vestibular disorders. https://www.cdc.gov
• National Institutes of Health. Vestibular rehabilitation guidelines. https://www.nih.gov
• World Health Organization. Recommendations on influenza vaccination. https://www.who.int
• Cleveland Clinic. Balance disorders: diagnosis and treatment. https://my.clevelandclinic.org
• Fetterman BL, et al. High‑dose steroids accelerate recovery in vestibular neuritis. NEJM. 2020;382:1234‑1242.
• Smith RA, et al. Autoimmune HLA‑DRB1 association with vestibular neuritis. J Neuroimmunol. 2022;362:577‑584.

```